January 2023

One question asked by the audience to Dr. Samatha was, “What is the possibility of preventing a lot of diseases using predictive and preventive medicine and using metabolic biomarkers at a very early stage for a lot of cases since the cost of tests after getting a disease is very expensive

Dr. Hima started the second panel discussion by thanking all the panelists for gracing the stage and accepting the invitation to come over and talk a little bit about personalized medicine. She introduced all the physicians who have been actively incorporating personalized medicine into their practice and saw what their perspective was on the floor and what was happening right now.

A recent study identified GATA4 and MYH6 as the potential risk genes responsible for septal defects in congenital heart disease. The results of this study were published in the journal, Gene.

A recent study illustrated that the same genotype can give rise to a biphasic phenotype in the same person or a reverse phenotype in someone from the same family in monogenic cases with hyperinsulinism. The results of this study were published in Reviews in Endocrine and Metabolic Disorders.

A recent study revealed new biology of abdominal aortic diameter (AAD)…

A recent study suggests that drug-gene pairs in anti-hypertensive…

Genetic testing in Cardiovascular Diseases…

A biomarker test for an enzyme, protein, or hormone for the heart is…

Cardiovascular disease (CVD) is one of the leading causes of death worldwide…

Monogenic diabetes is a rare condition which is caused due  to…